Score Overview
See the full market ranking โ
Agios Pharm fundamental performance
Between 2020 and 2025, revenue declined from $ 203M to $ 54M and net income went from -$ 327M to -$ 412M. Revenue increased in every one of those 5 years; net income in 2.
Between 2015 and 2025, revenue declined from $ 59M to $ 54M and net income went from -$ 117M to -$ 412M. Revenue increased in 8 of those 10 years; net income in 4.
Agios Pharm currently holds a 5-year HDB Score of 4.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 34.21 | โ |
1 Year2025-08-12 | $ 35.38 | -3.31% |
5 Years2021-08-12 | $ 44.05 | -22.34% |
10 Years2016-08-12 | $ 40.42 | -15.36% |
All Time2013-07-24 | $ 31.28 | 9.37% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2013-07-24 |
|---|---|---|---|---|---|
| Price | $ 34.21 | $ 35.38 | $ 44.05 | $ 40.42 | $ 31.28 |
| Return | โ | -3.31% | -22.34% | -15.36% | 9.37% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 98M | -$ 411M | $ 617M |
| 2025 | $ 54M | -$ 412M | $ 854M |
| 2024 | $ 36M | $ 673M | $ 893M |
| 2023 | $ 26M | -$ 352M | $ 776M |
| 2022 | $ 14M | -$ 231M | $ 783M |
| 2021 | $ 41.41K | $ 1.60B | $ 1.02B |
| 2020 | $ 203M | -$ 327M | $ 572M |
| 2019 | $ 117M | -$ 411M | $ 564M |
| 2018 | $ 94M | -$ 346M | $ 805M |
| 2017 | $ 43M | -$ 314M | $ 567M |
| 2016 | $ 69M | -$ 198M | $ 573M |
| 2015 | $ 59M | -$ 117M | $ 375M |
| 2014 | $ 65M | -$ 53M | $ 342M |
| IPO2013 | $ 25M | -$ 39M | $ 166M |
Explore beyond AGIO
You're looking at Agios Pharm. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
